Trial Profile
Open Label, Multi-center, Sequential Group Clinical Study to Determine the Safety and Efficacy of Escalating Dosing Regimens of Intravenous BAL8557 in the Prophylaxis of Patients Undergoing Chemotherapy for Acute Myeloid Leukemia
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Isavuconazole (Primary) ; Isavuconazole (Primary)
- Indications Mycoses
- Focus Adverse reactions
- Sponsors Astellas Pharma
- 26 Sep 2014 New trial record